US Bancorp’s LifeMD LFMD Stock Holding History

US Bancorp’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000	Closed	-$6K	–	4175
2021 Q3	$6K	Hold	1,000	–	–	﹤0.01%	3590
2021 Q2	$12K	Hold	1,000	–	–	﹤0.01%	3344
2021 Q1	$16K	Buy	+1,000	New	+$18K	﹤0.01%	3121

Other funds holding LFMD

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIA

Barry Investment Advisors New Bedford, Massachusetts $478M AUM 23.65% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp's LFMD Position: Q4 2021 in Review

US Bancorp sold out of LifeMD (LFMD) in Q4 2021, closing a stake of 1,000 shares — an estimated $6K sold.

US Bancorp first reported a position in LFMD in Q1 2021 and held it in 3 quarters. The position peaked at $16K in Q1 2021. 53 funds tracked by Wall St. Rank hold LFMD as of Q4 2021.

US Bancorp reported no remaining LifeMD position as of Q4 2021 after selling out during the quarter.
US Bancorp sold 1,000 LifeMD shares in Q4 2021, an estimated $6K.
US Bancorp first reported a position in LifeMD in Q1 2021 and held it in 3 quarters.
US Bancorp's LifeMD position peaked at $16K in Q1 2021.
53 funds tracked by Wall St. Rank held LifeMD as of Q4 2021.

Based on US Bancorp's 13F filing for Q4 2021, filed 11 Feb 2022.